Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human TMPRSS3 Anticorps:
anti-Mouse (Murine) TMPRSS3 Anticorps:
anti-Rat (Rattus) TMPRSS3 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal TMPRSS3 Primary Antibody pour ELISA, WB - ABIN566271
Guerrero, Wang, Bachvarova, Gregoire, Renaud, Plante, Bachvarov: A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation. dans Gynecologic oncology 2012
Cow (Bovine) Polyclonal TMPRSS3 Primary Antibody pour WB - ABIN2787338
Spellman, Ahmed, Dubach, Gardiner: Expression of trisomic proteins in Down syndrome model systems. dans Gene 2012
Human Polyclonal TMPRSS3 Primary Antibody pour ELISA, WB - ABIN262294
Lee, Park, Kim, Park: Pathogenic mutations but not polymorphisms in congenital and childhood onset autosomal recessive deafness disrupt the proteolytic activity of TMPRSS3. dans Journal of medical genetics 2003
knockdown of TMPRSS3 (Montrer TMPRSS4 Anticorps) inhibits proliferation, migration, and invasion in human nasopharyngeal carcinoma cells through the inactivation of the PI3K (Montrer PIK3CA Anticorps)/Akt (Montrer AKT1 Anticorps) signaling pathway. This study suggests that TMPRSS3 (Montrer TMPRSS4 Anticorps) may be a potential therapeutic target for the treatment of nasopharyngeal carcinoma
For those with a combination of severely pathogenic TMPRSS3 (Montrer TMPRSS4 Anticorps) variants, rapid aggravation of the residual hearing should be anticipated and treated accordingly. Our confirmation of the genotype-phenotype correlation of the TMPRSS3 (Montrer TMPRSS4 Anticorps) gene may pave the way for the establishment of a personalized auditory rehabilitation.
Our results indicate that mutations in TMPRSS3 (Montrer TMPRSS4 Anticorps) account for about 4.6% (7/151) of Chinese autosomal recessive nonsyndromic hearing loss cases lacking mutations in SLC26A4 (Montrer SLC26A4 Anticorps) or GJB2 (Montrer GJB2 Anticorps) and that the recurrent TMPRSS3 (Montrer TMPRSS4 Anticorps) mutation p.Ala306Thr is likely to be a founder mutation.
Given that a previous paper suggested TMPRSS3 (Montrer TMPRSS4 Anticorps) and GJB2 (Montrer GJB2 Anticorps) genes as responsible for a digenic form of hearing loss, our data support and reinforce this hypothesis.
In conclusion, TMPRSS3 (Montrer TMPRSS4 Anticorps) and TNFRSF11B (Montrer TNFRSF11B Anticorps) may have potential prognostic value to be used as tumor biomarkers in breast cancer patients.
different combinations of TMPRSS3 (Montrer TMPRSS4 Anticorps) mutations led to different hearing impairment phenotypes (DFNB8/DFNB10) in the Chinese family.
TMPRSS3 (Montrer TMPRSS4 Anticorps) mutations seem to be an important cause of autosomal recessive nonsyndromic hearing loss in Slovenia resulting in rather uniform phenotype with profound congenital hearing loss.
Study demonstrated that TMPRSS3 contributes to ovarian cancer cell proliferation, invasion and metastasis, probably via activation of the ERK1/2 signaling pathway.
TMPRSS3 (Montrer TMPRSS4 Anticorps) expression is an independent prognostic factor for breast cancer patients. Bioinformatic analysis of potential TMPRSS3 (Montrer TMPRSS4 Anticorps) binding proteins revealed that TMPRSS3 (Montrer TMPRSS4 Anticorps) could be a key regulator of cancer pathways.
Low expression levels of hepsin (Montrer HPN Anticorps) and TMPRSS3 (Montrer TMPRSS4 Anticorps) are associated with poor breast cancer survival
miR (Montrer MLXIP Anticorps)-204 has a role in suppressing cochlear spiral ganglion neuron survival in vitro by targeting TMPRSS3
Lack of Tmprss3 leads to a decrease in Kcnma1 (Montrer KCNMA1 Anticorps) potassium channels expression in cochlear inner hair cells.
The distribution of TMPRSS3 was observed in many regions of the mouse cochlea, but mainly in the spiral ganglion neurons.
Tmprss3 acts as a permissive factor for cochlear hair cells survival and activation at the onset of hearing and is required for saccular hair cell survival
This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described.
transmembrane protease, serine 3
, transmembrane protease serine 3-like
, serine protease TADG-12
, transmembrane protease serine 3
, tumor-associated differentially-expressed gene 12 protein
, transmembrane proteinase serine 3